98-12450. Revocation of Lather Brushes Regulation  

  • [Federal Register Volume 63, Number 91 (Tuesday, May 12, 1998)]
    [Rules and Regulations]
    [Pages 26077-26078]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-12450]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 1240
    
    [Docket No. 97P-0418]
    
    
    Revocation of Lather Brushes Regulation
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is revoking its 
    regulation pertaining to the treatment, sterilization, handling, 
    storage, marking, and inspection of lather brushes. FDA is revoking 
    this regulation because the regulation is no longer necessary to 
    protect the public health.
    
    FOR FURTHER INFORMATION CONTACT: Philip L. Chao, Policy Development and 
    Coordination Staff (HF-23), Food and Drug Administration, 5600 Fishers 
    Lane, Rockville, MD 20857, 301-827-3380.
    
    DATES: This final rule is effective June 11, 1998.
    SUPPLEMENTARY INFORMATION:
    
    I. Background
    
        In the Federal Register of October 20, 1997 (62 FR 54398), FDA 
    proposed to revoke a regulation pertaining to the treatment, 
    sterilization, handling, storage, marking, and inspection of lather 
    brushes. The preamble to the proposal explained that the lather brush 
    regulation was originally published in 1949 by the Federal Security 
    Agency and was intended to prevent cases of cutaneous anthrax through 
    lather brushes made from animal hair or bristles. A Government 
    reorganization transferred the Federal Security Agency's functions to 
    the then-Department of Health, Education, and Welfare (now known as the 
    Department of Health and Human Services), and responsibility for the 
    rule was later assigned, in 1975, to FDA. The rule was codified at 
    Sec. 1240.70 (21 CFR 1240.70).
        FDA proposed to revoke the regulation because it was unaware of any 
    reliance on the lather brush requirements or of any current concerns 
    associated with lather brushes and because the regulation was no longer 
    necessary to protect the public health. The proposal also noted that 
    the then-Center for Disease Control (now the Centers for Disease 
    Control and Prevention) revoked a similar lather brush regulation in 
    1985 on the grounds that no case of cutaneous anthrax in the United 
    States had been associated with lather brushes since 1930.
        FDA received no comments on the proposal. Consequently, this final 
    rule revokes Sec. 1240.70.
    
    II. Analysis of Impacts
    
        FDA has examined the impacts of the final rule under Executive 
    Order 12866 and the Regulatory Flexibility Act (5 U.S.C. 601-612). 
    Executive Order 12866 directs agencies to assess all costs and benefits 
    of available regulatory alternatives and, when regulation is necessary, 
    to select regulatory approaches that maximize net benefits (including 
    potential economic, environmental, public health and safety, and other 
    advantages; distributive impacts; and equity). The agency believes that 
    this final rule is consistent with the regulatory philosophy and 
    principles identified in the Executive Order. In addition, the final 
    rule is not a significant regulatory action as defined by the Executive 
    Order and so is not subject to review under the Executive Order.
        The Regulatory Flexibility Act requires agencies to analyze 
    regulatory options that would minimize any significant impact of a rule 
    on small entities. Because the final rule eliminates certain 
    manufacturing requirements for lather brushes, the agency certifies 
    that the final rule will not have a significant economic impact on a 
    substantial number of small entities. Therefore, under the Regulatory 
    Flexibility Act, no further analysis is required.
    
    III. Environmental Impact
    
        The agency has determined under 21 CFR 25.30(h) that this action is 
    of a type that does not individually or cumulatively have a significant 
    effect on the human environment. Therefore, neither an environmental 
    assessment nor an environmental impact statement is required.
    
    IV. Paperwork Reduction Act of 1995
    
        This final rule contains no collections of information. Therefore, 
    clearance by the Office of Management and Budget under the Paperwork 
    Reduction Act of 1995 is not required.
    
    [[Page 26078]]
    
    List of Subjects in 21 CFR Part 1240
    
        Communicable diseases, Public health, Travel restrictions, Water 
    supply.
        Therefore, under the Public Health Service Act and under the 
    authority delegated to the Commissioner of Food and Drugs, 21 CFR part 
    1240 is amended as follows:
    
    PART 1240--CONTROL OF COMMUNICABLE DISEASES
    
        1. The authority citation for part 1240 continues to read as 
    follows:
    
        Authority: 42 U.S.C. 216, 243, 264, 271.
    
    Sec. 1240.70  [Removed]
    
        2. Section 1240.70 Lather brushes is removed.
    
        Dated: May 4, 1998.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 98-12450 Filed 5-11-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
6/11/1998
Published:
05/12/1998
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
98-12450
Dates:
This final rule is effective June 11, 1998. SUPPLEMENTARY INFORMATION:
Pages:
26077-26078 (2 pages)
Docket Numbers:
Docket No. 97P-0418
PDF File:
98-12450.pdf
CFR: (1)
21 CFR 1240.70